In other words, you’ve never seen dropouts in a clinical trial reported as a ratio of one set of arms to another. You could’ve just said this and saved on the back and forth.
Nope, I'd be very surprised if I hadn't seen it. But dropout rates (ratio or otherwise) are not mentioned in PRs anywhere near as commonly as efficacy rates, for example. So the chance of my remembering it or finding it in a search goes way way down. As you undoubtedly knew.
Do you seriously want to continue this feeble line of debate?
Come now. It is you who is employing the debating tricks.
What’s much more relevant, IMO, is how many of the patients on Proellex dropped out and why they dropped out.
Find a company, any company, that posted exact reasons for their drop outs in a PR. I suspect you can find one - but I'd bet I can find 10:1 PRs about drop out rates that do no list anything other than very uninformative categories.
Market Data 
Markets 
AI
